BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9987444)

  • 1. Determining the utility and effectiveness of the NeoPath AutoPap 300 QC System used routinely.
    Fetterman B; Pawlick G; Koo H; Hartinger J; Gilbert C; Connell S
    Acta Cytol; 1999; 43(1):13-22. PubMed ID: 9987444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does use of the AutoPap assisted primary screener improve cytologic diagnosis?
    Bibbo M; Hawthorne C; Zimmerman B
    Acta Cytol; 1999; 43(1):23-6. PubMed ID: 9987445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
    Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
    Cancer; 1997 Dec; 81(6):337-42. PubMed ID: 9438458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
    Marshall CJ; Rowe L; Bentz JS
    Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.
    Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
    Cancer; 1997 Dec; 81(6):343-7. PubMed ID: 9438459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
    Wertlake P
    J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of automated cervical cytology rescreening using the AutoPap 300 QC System.
    Stevens MW; Milne AJ; James KA; Brancheau D; Ellison D; Kuan L
    Diagn Cytopathol; 1997 Jun; 16(6):505-12. PubMed ID: 9181316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter comparison of manual and automated screening of AutoCyte gynecologic preparations.
    Bishop JW; Kaufman RH; Taylor DA
    Acta Cytol; 1999; 43(1):34-8. PubMed ID: 9987448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the AutoPap primary screening system at Jefferson University Hospital.
    Bibbo M; Hawthorne C
    Acta Cytol; 1999; 43(1):27-9. PubMed ID: 9987446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct-to-vial use of the AutoCyte PREP liquid-based preparation for cervical-vaginal specimens in three European laboratories.
    Vassilakos P; Saurel J; Rondez R
    Acta Cytol; 1999; 43(1):65-8. PubMed ID: 9987452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAPNET for cervical cytology screening. Experience in Greece.
    Veneti S; Papaefthimiou M; Symiakaki H; Ioannidou-Mouzaka L
    Acta Cytol; 1999; 43(1):30-3. PubMed ID: 9987447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AutoCyte Interactive Screening System. Experience at a university hospital cytology laboratory.
    Howell LP; Belk T; Agdigos R; Davis R; Lowe J
    Acta Cytol; 1999; 43(1):58-64. PubMed ID: 9987451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated cervical cytology: meta-analyses of the performance of the AutoPap 300 QC System.
    Abulafia O; Sherer DM
    Obstet Gynecol Surv; 1999 Jul; 54(7):469-76. PubMed ID: 10394585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NeoPath, Inc. NeoPath AutoPap 300 Automatic Pap Screener System.
    Patten SF; Lee JS; Nelson AC
    Acta Cytol; 1996; 40(1):45-52. PubMed ID: 8604574
    [No Abstract]   [Full Text] [Related]  

  • 15. A feasibility study of the AutoPap system location-guided screening.
    Lee JS; Kuan L; Oh S; Patten FW; Wilbur DC
    Acta Cytol; 1998; 42(1):221-6. PubMed ID: 9479344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical trial of the AutoPap 300 QC system for quality control of cervicovaginal cytology in the clinical laboratory.
    Colgan TJ; Patten SF; Lee JS
    Acta Cytol; 1995; 39(6):1191-8. PubMed ID: 7483997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AutoPap 300 QC system scoring of cervical smears without "epithelial cell abnormalities".
    Colgan TJ; Bon N; Lee JS; Patten SF
    Acta Cytol; 1997; 41(1):45-9. PubMed ID: 9022725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap System: results of a primary screening clinical trial.
    Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ; Dax Taylor D
    Cancer; 1999 Dec; 87(6):354-8. PubMed ID: 10603189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of the AutoPap 300 QC System for cervical cytologic abnormalities. Biopsy data confirmation.
    Wilbur DC; Bonfiglio TA; Rutkowski MA; Atkison KM; Richart RM; Lee JS; Patten SF
    Acta Cytol; 1996; 40(1):127-32. PubMed ID: 8604565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Djemli A; Khetani K; Auger M
    Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.